Polysaccharide vaccine

This page covers all Polysaccharide vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Streptococcus pneumoniae capsular polysaccharides (23 serotypes), Neisseria meningitidis serogroup A capsular polysaccharide, Streptococcus pneumoniae capsular polysaccharides.

Targets

Streptococcus pneumoniae capsular polysaccharides (23 serotypes) · Neisseria meningitidis serogroup A capsular polysaccharide · Streptococcus pneumoniae capsular polysaccharides · Salmonella typhi Vi polysaccharide capsular antigen · Neisseria meningitidis serogroups A and C polysaccharide capsule

Marketed (8)

• Pneumococcal polysaccharide vaccine · Celgene · Immunology / Infectious Disease
  Pneumococcal polysaccharide vaccine stimulates the immune system to produce antibodies against multiple serotypes of Streptococcus pneumoniae, providing protection against pneumococcal infection.
• ProDiax-23 (PPSV23) · Korea University Guro Hospital · Immunology / Infectious Disease
  PPSV23 is a pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.
• Meningococcal A (control) · International Vaccine Institute · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies against Neisseria meningitidis serogroup A polysaccharide capsule.
• PPV23 alone · Korea University Guro Hospital · Immunology / Infectious Disease
  PPV23 is a pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.
• PPV Vaccine · Fakultas Kedokteran Universitas Indonesia · Immunology / Infectious Disease
  PPV vaccine stimulates the immune system to produce antibodies against pneumococcal polysaccharide antigens, providing protection against Streptococcus pneumoniae infection.
• Typhoid Vi vaccine · International Vaccine Institute · Immunology / Infectious Disease
  The Typhoid Vi vaccine stimulates the immune system to produce antibodies and cellular immunity against Salmonella typhi by presenting the bacterial Vi polysaccharide capsular antigen.
• Pneumovax™23 · Merck Sharp & Dohme LLC · Immunology
  Pneumovax 23 is a polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae bacteria.
• polyvalent pneumococcal vaccine · Astellas Pharma Inc · Immunology / Infectious Disease
  A polyvalent pneumococcal vaccine stimulates the immune system to produce antibodies against multiple serotypes of Streptococcus pneumoniae bacteria.

Phase 3 pipeline (5)

• A+C Meningococcal Polysaccharide Vaccine · Hualan Biological Engineering, Inc. · Immunology / Infectious Disease
  This vaccine stimulates the immune system to produce antibodies against meningococcal serogroups A and C polysaccharide antigens, providing protection against meningococcal disease.
• Pneumovax (PPSV23) · University of Minnesota · Immunology
  Pneumovax (PPSV23) is a polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae bacteria.
• Pneumo23 / Pneumovax · University Hospital, Montpellier · Immunology / Infectious Disease
  Pneumo23 is a polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.
• vaccination PNEUMOVAX 23 · Walvax Biotechnology Co., Ltd. · Immunology / Infectious Disease
  PNEUMOVAX 23 is a polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.
• 23-PPV · Hoffmann-La Roche · Immunology / Infectious Disease
  23-PPV is a pneumococcal polysaccharide vaccine that stimulates the immune system to produce antibodies against 23 serotypes of Streptococcus pneumoniae.